308 related articles for article (PubMed ID: 9050836)
1. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
Zhao Q; Yang XL; Holtzclaw WD; Talalay P
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1669-74. PubMed ID: 9050836
[TBL] [Abstract][Full Text] [Related]
2. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human quinone reductase type 2, a metalloflavoprotein.
Foster CE; Bianchet MA; Talalay P; Zhao Q; Amzel LM
Biochemistry; 1999 Aug; 38(31):9881-6. PubMed ID: 10433694
[TBL] [Abstract][Full Text] [Related]
4. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
Li R; Bianchet MA; Talalay P; Amzel LM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
[TBL] [Abstract][Full Text] [Related]
5. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
Cavelier G; Amzel LM
Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659
[TBL] [Abstract][Full Text] [Related]
7. High-resolution studies of hydride transfer in the ferredoxin:NADP
Kean KM; Carpenter RA; Pandini V; Zanetti G; Hall AR; Faber R; Aliverti A; Karplus PA
FEBS J; 2017 Oct; 284(19):3302-3319. PubMed ID: 28783258
[TBL] [Abstract][Full Text] [Related]
8. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
Chen S; Deng PS; Bailey JM; Swiderek KM
Protein Sci; 1994 Jan; 3(1):51-7. PubMed ID: 7511454
[TBL] [Abstract][Full Text] [Related]
9. Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis.
Chen S; Clarke PE; Martino PA; Deng PS; Yeh CH; Lee TD; Prochaska HJ; Talalay P
Protein Sci; 1994 Aug; 3(8):1296-304. PubMed ID: 7527260
[TBL] [Abstract][Full Text] [Related]
10. X-ray structural studies of quinone reductase 2 nanomolar range inhibitors.
Pegan SD; Sturdy M; Ferry G; Delagrange P; Boutin JA; Mesecar AD
Protein Sci; 2011 Jul; 20(7):1182-95. PubMed ID: 21538647
[TBL] [Abstract][Full Text] [Related]
11. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes.
Cui K; Ma Q; Lu AY; Yang CS
Arch Biochem Biophys; 1995 Nov; 323(2):265-73. PubMed ID: 7487087
[TBL] [Abstract][Full Text] [Related]
12. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
[TBL] [Abstract][Full Text] [Related]
14. Structure, function, and mechanism of cytosolic quinone reductases.
Bianchet MA; Erdemli SB; Amzel LM
Vitam Horm; 2008; 78():63-84. PubMed ID: 18374190
[TBL] [Abstract][Full Text] [Related]
15. FAD-binding site and NADP reactivity in human renalase: a new enzyme involved in blood pressure regulation.
Milani M; Ciriello F; Baroni S; Pandini V; Canevari G; Bolognesi M; Aliverti A
J Mol Biol; 2011 Aug; 411(2):463-73. PubMed ID: 21699903
[TBL] [Abstract][Full Text] [Related]
16. NAD(P)H:(Quinone-Acceptor) Oxidoreductase of Tobacco Leaves Is a Flavin Mononucleotide-Containing Flavoenzyme.
Sparla F; Tedeschi G; Trost P
Plant Physiol; 1996 Sep; 112(1):249-258. PubMed ID: 12226388
[TBL] [Abstract][Full Text] [Related]
17. Purification and crystallization of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase by cibacron blue affinity chromatography: identification of a new and potent inhibitor.
Prochaska HJ
Arch Biochem Biophys; 1988 Dec; 267(2):529-38. PubMed ID: 3214167
[TBL] [Abstract][Full Text] [Related]
18. Expression of rat liver NAD(P)H:quinone-acceptor oxidoreductase in Escherichia coli and mutagenesis in vitro at Arg-177.
Chen HH; Ma JX; Forrest GL; Deng PS; Martino PA; Lee TD; Chen S
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):855-60. PubMed ID: 1622401
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling.
Chen S; Wu K; Zhang D; Sherman M; Knox R; Yang CS
Mol Pharmacol; 1999 Aug; 56(2):272-8. PubMed ID: 10419545
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NAD(P)H:quinone acceptor oxidoreductase by flavones: a structure-activity study.
Chen S; Hwang J; Deng PS
Arch Biochem Biophys; 1993 Apr; 302(1):72-7. PubMed ID: 8470908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
